ICONIC THERAPEUTICS

Iconic Therapeutics develops and commercializes immunoconjugate proteins that trigger the immune system to destroy invader cells. It is a biopharmaceutical company that has an exclusive license on issued Yale University patents for a novel recombinant protein called hI-con1. hI-con1 binds tissue factor (TF), triggering natural killer cells to selectively destroy pathologic neovascular blood vessels. Such cells include choroidal neovascularization (CNV) associated with wet age-related macular deg... eneration (wet AMD) and TF-expressing cancer cells and tumor-associated pathologic blood vessels (PBV). In addition to this cell-mediated cytotoxicity, hI-con1 may also interrupt the positive feedback loop between tissue factor and vascular endothelial growth factor (VEGF), thereby reducing VEGF levels. Phase 1 studies with hl-con1 are complete and no dose limited toxicities were observed. Evidence of dose-related biologic activity was observed.

#SimilarOrganizations #People #Financial #Website #More

ICONIC THERAPEUTICS

Social Links:

Industry:

Biopharma Biotechnology Therapeutics

Founded:

2002-01-01

Address:

South San Francisco, California, United States

Country:

United States

Website Url:

http://www.iconictherapeutics.com

Total Employee:

11+

Status:

Active

Contact:

(650) 437-1000

Email Addresses:

[email protected]

Total Funding:

82.85 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Google Universal Analytics Global Site Tag Nginx Euro

Similar Organizations

rainier-therapeutics-logo

Rainier Therapeutics

Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.

Current Advisors List

johan-kördel_image

Johan Kördel Member of the Board of Directors @ Iconic Therapeutics
Board_member

bruce-robertson_image

Bruce Robertson Board of Directors @ Iconic Therapeutics
Board_member

todd-foley_image

Todd Foley Board of Directors @ Iconic Therapeutics
Board_member

not_available_image

Jonathan Soderstrom Board of Directors @ Iconic Therapeutics
Board_member

Current Employees Featured

not_available_image

Patrick W. Trown
Patrick W. Trown Chief Scientist @ Iconic Therapeutics
Chief Scientist

george-g-montgomery_image

George G. Montgomery
George G. Montgomery Senior Vice President, Financial Strategy @ Iconic Therapeutics
Senior Vice President, Financial Strategy
2015-04-01

gabriela-burian_image